跳至主要内容
临床试验/NL-OMON49017
NL-OMON49017已完成不适用

Safety and Performance Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the reduction of pathogen load from the blood in septic patients with suspected, life-threatening bloodstream infection. - CP015

Exthera Medical Europe B.V.0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients with sepsis and suspected bloodstream infection
  • 2. Be >= 18 years old and <=90 years old
  • 3. Adults receiving antibiotic therapy
  • 4. Increase of at least two points of the Sequential Organ Failure Assessment
  • (SOFA) score
  • 5. Subjects that presents Procalcitonin (PCT) levels >0,5 ng/mL

排除标准

  • 1. Subject is currently participating in another clinical investigation
  • 2. Pregnant or nursing subjects and those who plan pregnancy during the
  • clinical investigation follow-up period
  • 3. Presence of comorbid conditions, or other medical, social, or psychological
  • conditions that, in the investigator*s opinion, could limit the subject*s
  • ability to participate in the clinical investigation or to comply with
  • follow-up requirements, or impact the scientific soundness of the clinical
  • investigation results
  • 4. The first dose of the current antibiotic therapy was > 24 h before screening
  • 5. Have Child-Pugh Class C cirrhosis
  • 6. Have platelet count <30.000/uL
  • 7. Contraindications for heparin sodium for injection
  • 8. Subjects demonstrating any contraindication for this treatment as described

研究者

发起方
Exthera Medical Europe B.V.

相似试验